Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03192072 · ClinicalTrials.gov registry record
A Rapid Test for Acute Respiratory Illness
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 783
- Enrollment target
NCT03192072 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 783 participants.
The verdict
NCT03192072 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 783 participants
- Enrollment target
Study Summary
The primary purpose of this study is to support the development of a host response test for acute respiratory illness to identify bacterial, viral or NB/NV etiologies as compared to a clinical adjudication reference standard. Secondary objectives include: 1. Evaluate the effect of age on the performance of the HR-ARI test 2. Evaluate the effect of race/ethnicity on the performance of the HR-ARI test 3. Evaluate the effect of geography on the performance of the HR-ARI test
Interventions
- DIAGNOSTIC_TEST Host Gene Expression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 783 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2019-12-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03192072
The ClinicalTrials.gov registry entry for NCT03192072 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 783 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Host Gene Expression is the first listed.
NCT03192072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03192072 about?
NCT03192072 is a clinical study titled "A Rapid Test for Acute Respiratory Illness". The primary purpose of this study is to support the development of a host response test for acute respiratory illness to identify bacterial, viral or NB/NV etiologies as compared to a clinical adjudication reference standard. Secondary objectives include: 1. Evaluate the effect of age on the perfo...
What is the current status of trial NCT03192072?
This trial is currently completed. The enrollment target is 783 participants. The study started on 2017-07-17. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT03192072?
The interventions under investigation include: Host Gene Expression (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03192072?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.